Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU Genetics Investing
Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Biotech Investing
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments Biotech Investing
Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy Genetics Investing
Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate Genetics Investing
Genetic Technologies Completes Two Genetic Risk Tests for Colorectal and Breast Cancer Genetics Investing